American Century Companies’s Crescent Biopharma CBIO Stock Holding History

American Century Companies's CBIO Position: Q2 2026 in Review

American Century Companies opened a new position in Crescent Biopharma (CBIO) in Q2 2026: 22,805 shares worth $410K. The stake represents ﹤0.01% of the portfolio and ranks #2631 among its holdings. This is a return to the name: American Century Companies previously reported a position in CBIO as recently as Q1 2024.

American Century Companies first reported a position in CBIO in Q1 2024 and has held it in 2 quarters since. 82 funds tracked by Wall St. Rank hold CBIO as of Q2 2026.

• American Century Companies held 22,805 shares of Crescent Biopharma worth $410K as of Q2 2026.
• Crescent Biopharma was a new American Century Companies position in Q2 2026.
• Crescent Biopharma made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2631 holding.
• American Century Companies first reported a position in Crescent Biopharma in Q1 2024 and has held it in 2 quarters since.
• 82 funds tracked by Wall St. Rank held Crescent Biopharma as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.